Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEC Approves Final Proxy Access Rules 8/25/10 non-accelerated filer

Are you suggesting that even after the SEC stayed the implementation of the Rule pending the outcome of the Appeal, which Vacated the Rule, California can simply go ahead, against the direction of the Court of Appeals, and make it law?

I humbly suggest you rethink your response.

.

.

.

Be well

Share
New Message
Please login to post a reply